Caliber Imaging & Diagnostics, Inc. LCDX

Company Overview

Caliber Imaging & Diagnostics, Inc. (NASDAQ: LCDX) is a medical technology company focused on non-invasive imaging systems and artificial intelligence-enabled software for dermatology and related clinical applications. The company develops optical imaging platforms designed to assist physicians in the visualization and assessment of skin lesions, with a primary emphasis on early skin cancer detection and diagnostic support. Caliber operates within the broader medical devices, digital pathology, and healthcare imaging industries.

The company’s primary commercial platform is the VivaScope product line, which uses reflectance confocal microscopy (RCM) technology to generate cellular-level images of the skin in real time without requiring tissue excision. Revenue is primarily generated through sales of imaging systems, recurring service agreements, consumables, and software-related offerings. Caliber’s customer base includes dermatologists, academic medical centers, research institutions, and specialty clinics in both the United States and international markets. The company evolved from technology initiatives originally associated with Lucid, Inc., later rebranding as Caliber Imaging & Diagnostics to reflect its broader focus on imaging technologies and AI-supported diagnostics.